Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Sep 23:3:986672.
doi: 10.3389/fcdhc.2022.986672. eCollection 2022.

Digital algorithm-guided insulin therapy in home healthcare for elderly persons with type 2 diabetes: A proof-of-concept study

Affiliations

Digital algorithm-guided insulin therapy in home healthcare for elderly persons with type 2 diabetes: A proof-of-concept study

Julia Kopanz et al. Front Clin Diabetes Healthc. .

Abstract

GlucoTab@MobileCare, a digital workflow and decision support system with integrated basal and basal-plus insulin algorithm was investigated for user acceptance, safety and efficacy in persons with type 2 diabetes receiving home health care by nurses. During a three months study nine participants (five female, age 77 ± 10 years, HbA1c 60 ± 13 mmol/mol (study start) vs. 57 ± 12 mmol/mol (study end) received basal or basal-plus insulin therapy as suggested by the digital system. In total 95% of all suggested tasks (blood glucose (BG) measurements, insulin dose calculations, insulin injections) were performed according to the digital system. Mean morning BG was 171 ± 68 mg/dL in the first study month vs. 145 ± 35 mg/dL in the last study month, indicating a reduced glycemic variability of 33 mg/dL (standard deviation). No hypoglycemic episode < 54 mg/dL occurred. User's adherence was high and the digital system supported a safe and effective treatment. Larger scale studies are needed to confirm findings under routine care.

German clinical trials register id: DRKS00015059.

Keywords: algorithm; digital; elderly; home healthcare; insulin therapy; type 2 diabetes.

PubMed Disclaimer

Conflict of interest statement

JM, FS, TP and KD are founders of the decide Clinical Software Ltd. JM is a member in the advisory board of Boehringer Ingelheim, Eli Lilly, Medtronic, Prediktor A/S, Roche Diabetes Care, Sanofi-Aventis and received speaker honoraria from Abbott Diabetes Care, AstraZeneca, Dexcom, Eli Lilly, MSD, NovoNordisk A/S, Roche Diabetes Care, Sanofi, and Servier. FA received speaker honoraria from Eli Lilly, Merck Sharp & Dome, Boehringer Ingelheim, Astra Zeneca, Sanofi Aventis, Amgen and travel grants from Sanofi, Novo Nordisk, Takeda, Merck Sharp & Dome and Amgen. TP is an advisory board member of Novo Nordisk A/S, consultant for Roche Diabetes Care, Novo Nordisk A/S, Eli Lilly & Co, Infineon, Carnegie Bank, shareholder of decide Clinical Software GmbH, and is on speaker’s bureau of Novo Nordisk A/S and Astra Zeneca. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Figures

Figure 1
Figure 1
Glycemic management during digital algorithm-guided insulin therapy: (A) Mean daily morning BG over all treatment days (B) Morning BG values grouped by study month.

References

    1. American Diabetes Association . 12. older adults: Standards of medical care in diabetes–2021. Diabetes Care (2021) 44:S168–79. doi: 10.2337/dc21-S012 - DOI - PubMed
    1. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, et al. . Diabetes in older adults. Diabetes Care (2012) 35:2650–64. doi: 10.2337/dc12-1801 - DOI - PMC - PubMed
    1. Inzucchi SE, Bergenstal RM, Buse JB, Diamant M, Ferrannini E, Nauck M, et al. . Management of hyperglycemia in type 2 diabetes: A patient-centered approach: position statement of the American diabetes association (ADA) and the European association for the study of diabetes (EASD). Diabetes Care (2012) 35:1364–79. doi: 10.2337/dc12-0413 - DOI - PMC - PubMed
    1. Dunning T, Sinclair A, Colagiuri S. “New IDF guideline for managing type 2 diabetes in older people,”. Diabetes Res. Clin. Pract. (2014) 103:538–40. doi: 10.1016/j.diabres.2014.03.005 - DOI - PubMed
    1. Sinclair A, Dunning T, Rodriguez-Mañas L. Diabetes in older people: new insights and remaining challenges. Lancet Diabetes Endocrinol. (2015) 3:275–85. doi: 10.1016/S2213-8587(14)70176-7 - DOI - PubMed

LinkOut - more resources